Commission

Get our monthly newsletter

Follow us on social media

CEO welcomes the very strongly worded final ruling by European Ombudsman Emily O’Reilly in her inquiry into the Commission’s implementation of UN rules for contacts with tobacco industry lobbyists.

You have probably never heard of AMISA2. But it turns out that AMISA2 and its predecessor AMISA have had staggeringly regular high-level access to senior EU decision-makers for decades. It is a quiet but persistent presence operating in the shadows of the Brussels bubble.

The response to two complaints about broken rules and dodgy data in the lobby register confirms the current system is toothless, argues CEO.

Splits occur within European Commission, as European Parliament, Ombudsman and NGOs increase the pressure for implementing UN rules for contacts with tobacco industry lobbyists.

Lobby Planet 2017 banner

We pay our taxes, so why don’t corporations? The Big Four are embedded in EU policy-making on tax avoidance and this report concludes that it is time to kick this industry out of EU anti-tax avoidance policy.

Industry lobbyists are spending millions of euros to influence an upcoming EU decision on labelling titanium dioxide – found in everyday products like sunscreen – a “suspected carcinogen”. The lobbying is led by an unregistered trade association and a public relations consultancy; nonetheless, they appear to have the ear of member states and the European Commission.

In her final decision on European Central Bank (ECB) President Mario Draghi’s membership of the Group of Thirty (G30), the European Ombudsman Emily O’Reilly has voiced disappointment about the bank’s reluctance to follow her recommendation to suspend Draghi’s G30 membership and to bar future presidents from joining the group.

Documents released to Corporate Europe Observatory following a Freedom of Information request reveal how pro-biotech lobby platform Public Research Regulation Initiative (PRRI) unites industry, researchers and regulators in ‘like-minded’ groups to influence crucial international biosafety talks under the UN Convention on Biological Diversity (CBD).